BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,342,514 | +1.9% | 1,460,807 | +1.3% | 0.00% | 0.0% |
| Q2 2023 | $10,147,491 | -14.5% | 1,441,405 | +1.3% | 0.00% | -25.0% |
| Q1 2023 | $11,868,821 | -27.2% | 1,423,120 | +0.2% | 0.00% | -20.0% |
| Q4 2022 | $16,306,043 | -6.6% | 1,420,387 | +2.5% | 0.01% | -16.7% |
| Q3 2022 | $17,466,000 | +21.6% | 1,386,148 | +2.1% | 0.01% | +20.0% |
| Q2 2022 | $14,358,000 | -34.4% | 1,357,003 | +0.8% | 0.01% | -28.6% |
| Q1 2022 | $21,900,000 | +24.0% | 1,346,841 | +5.6% | 0.01% | +40.0% |
| Q4 2021 | $17,657,000 | -1.2% | 1,274,815 | +2.5% | 0.01% | -16.7% |
| Q3 2021 | $17,879,000 | -7.8% | 1,244,166 | +1.4% | 0.01% | 0.0% |
| Q2 2021 | $19,401,000 | +58.1% | 1,227,111 | +1.7% | 0.01% | +50.0% |
| Q1 2021 | $12,275,000 | +41.0% | 1,206,966 | +3.3% | 0.00% | +33.3% |
| Q4 2020 | $8,707,000 | +116.6% | 1,168,691 | -0.1% | 0.00% | +50.0% |
| Q3 2020 | $4,020,000 | -9.1% | 1,170,046 | +26.1% | 0.00% | 0.0% |
| Q2 2020 | $4,422,000 | +157.2% | 927,944 | +8.0% | 0.00% | +100.0% |
| Q1 2020 | $1,719,000 | -40.4% | 859,007 | +2.8% | 0.00% | -50.0% |
| Q4 2019 | $2,882,000 | +74.7% | 835,249 | +45.1% | 0.00% | +100.0% |
| Q3 2019 | $1,650,000 | -33.3% | 575,806 | -11.8% | 0.00% | -50.0% |
| Q2 2019 | $2,474,000 | -61.0% | 652,733 | -16.2% | 0.00% | -50.0% |
| Q1 2019 | $6,345,000 | +31.5% | 779,365 | +30.4% | 0.00% | 0.0% |
| Q4 2018 | $4,825,000 | +2.7% | 597,822 | -2.9% | 0.00% | +33.3% |
| Q3 2018 | $4,700,000 | +58.0% | 615,903 | +18.7% | 0.00% | +50.0% |
| Q2 2018 | $2,975,000 | +27.0% | 519,060 | +5.7% | 0.00% | 0.0% |
| Q1 2018 | $2,342,000 | -4.0% | 490,976 | -1.2% | 0.00% | 0.0% |
| Q4 2017 | $2,440,000 | +45.4% | 496,792 | +55.2% | 0.00% | +100.0% |
| Q3 2017 | $1,678,000 | -2.0% | 320,078 | +4.0% | 0.00% | -50.0% |
| Q2 2017 | $1,712,000 | -38.9% | 307,811 | -7.7% | 0.00% | -33.3% |
| Q1 2017 | $2,801,000 | +63.5% | 333,373 | +23.2% | 0.00% | +50.0% |
| Q4 2016 | $1,713,000 | +50.9% | 270,581 | +5.2% | 0.00% | +100.0% |
| Q3 2016 | $1,135,000 | +62.6% | 257,183 | +4.7% | 0.00% | 0.0% |
| Q2 2016 | $698,000 | +1.7% | 245,729 | +1.5% | 0.00% | 0.0% |
| Q1 2016 | $686,000 | -75.0% | 242,201 | -8.9% | 0.00% | -75.0% |
| Q4 2015 | $2,745,000 | -2.0% | 265,970 | +8.2% | 0.00% | 0.0% |
| Q3 2015 | $2,802,000 | -10.6% | 245,760 | +17.1% | 0.00% | 0.0% |
| Q2 2015 | $3,134,000 | +70.0% | 209,875 | +2.8% | 0.00% | +33.3% |
| Q1 2015 | $1,844,000 | -68.3% | 204,106 | -57.3% | 0.00% | -66.7% |
| Q4 2014 | $5,818,000 | +32.2% | 478,383 | +6.3% | 0.01% | +28.6% |
| Q3 2014 | $4,402,000 | +38.1% | 450,021 | +80.0% | 0.01% | +40.0% |
| Q2 2014 | $3,187,000 | +1159.7% | 249,960 | +945.9% | 0.01% | – |
| Q1 2014 | $253,000 | +39.0% | 23,900 | 0.0% | 0.00% | – |
| Q4 2013 | $182,000 | 0.0% | 23,900 | 0.0% | 0.00% | – |
| Q3 2013 | $182,000 | +366.7% | 23,900 | 0.0% | 0.00% | – |
| Q2 2013 | $39,000 | – | 23,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |